Jaka jest cena za Galmed Pharmaceuticals Ltd. (GLMD)

Cena za Galmed Pharmaceuticals Ltd. (GLMD) wynosi $0.5225

Jaka jest kapitalizacja rynkowa dla Galmed Pharmaceuticals Ltd. (GLMD)

Kapitalizacja rynkowa dla Galmed Pharmaceuticals Ltd. (GLMD) wynosi $4.32M

Galmed Pharmaceuticals Ltd. (GLMD) Akcje w Obiegu

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.

Rok	Akcje w obrocie	Zmień
Za mało danych dla podanych dat.

Rok

Akcje w obrocie

Zmień

Za mało danych dla podanych dat.

Firma	Akcje w obrocie	Różnica	Kraj
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	-	US
Argenx SE ARGX.US	62.19M	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	0.00	-	BE

Firma

Akcje w obrocie

Różnica

Kraj